窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Apr 7 2026

Full Issue

Colorado Bill Would Shield So-Called Orphan Drugs From Pricing Caps

The measure is facing pushback because it has the potential to ensnare FDA-approved medications prescribed for common conditions that also are used to treat rare diseases. Plus, news on Medicaid cuts and conversion therapy.

For the second time in two years, a bill is moving through the Colorado legislature that would exempt orphan drugs, which are used to treat rare diseases, from pricing caps that might be pursued by the states Prescription Drug Affordability Board a panel whose work is being closely watched elsewhere in the country. The effort reflects concerns that patients may lose access to these drugs if pharmaceutical companies halt sales of such treatments in the state. But opponents argue exemptions would unnecessarily extend to numerous big-selling medicines for common conditions that thanks to regulatory endorsements also happen to have an orphan designation. (Silverman, 4/6)

As the Medicaid cuts from H.R. 1 begin to settle in, states are looking for workarounds to continue funding their programs. Iowa Republican Gov. Kim Reynolds signed a bill March 25 allowing a steeper HMO tax, which will also affect managed care organizations, to bolster the states Medicaid program. The tax would not be levied on just HMO premiums, but would instead apply to all taxable funds beyond those from federal HHS. With CMS approval, a 3.5% tax rate could be retroactively applied from January until September 2026. The rate would then drop to 0.95%. (Casolo, 4/6)

窪蹋勛圖厙 News: This Northern Cheyenne Doula Was About To Start Getting Paid Then Medicaid Cuts Hit

Misty Pipe had about an hour before her shift began at the post office. She used that time to check in on a new mom who lives a few miles outside this town at the heart of the Northern Cheyenne Indian Reservation. A mom of seven, Pipe is a doula on the reservation who supports new and expectant parents. She does that work free, around her day job. Thats because in this town of about 2,000 people, the closest hospital that delivers babies is 100 miles away. Women need this help, Pipe said. (Houghton, 4/7)

The Supreme Courts ruling last week against bans on conversion therapy is stirring debate around free speech, with critics pointing to inconsistencies in the standard applied to bans on abortion and drag shows.In its ruling on Colorados 2019 ban on conversion therapy in the case of Chiles v. Salazar, the Supreme Court found that a lower court had erred in upholding it because the law regulates speech based on viewpoint.(Choi, 4/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF